Quick Answer
Solid Biosciences Inc. reported Total Revenue of $8.09 million for the year ending 2022.
- Solid Biosciences Inc. showed a decrease of -40.6% in Total Revenue from 2021 to 2022.
- This data is from Solid Biosciences Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2023.
- XBRL data for this metric is available from 2016 to 2022 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $0.00 | Q2 2017: $0.00 | Q3 2017: $0.00 | Q4 2017: $0.00 | Q1 2018: $0.00 | Q2 2018: $0.00 | Q3 2018: $0.00 | Q4 2018: $0.00 | Q1 2019: $0.00 | Q2 2019: $0.00 | Q3 2019: $0.00 | Q4 2019: $0.00 | Q1 2020: $0.00 | Q2 2020: $0.00 | Q3 2020: $0.00.
- Historical annual values: Fiscal year 2022: $8.09 million | Fiscal year 2021: $13.62 million | Fiscal year 2020: $0.00 | Fiscal year 2019: $0.00 | Fiscal year 2018: $0.00 | Fiscal year 2017: $0.00 | Fiscal year 2016: $0.00.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: